Wiadomości JNJ.US

Johnson & Johnson (NYSE: JNJ) reported its third quarter 2025 earnings results today. Reported sales increased 6.8% year-over-year to $24 billion. Operational sales were up 5.4%. GAAP net earnings rose 91% to $5.2 billion, or $2.12 per share, compared to last year. Adjusted EPS grew 16% to $2.80. For the full year of 2025, reported […] The post JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q3 2025 financial results first appeared on AlphaStreet.

For Johnson & Johnson (NYSE: JNJ), 2025 has been a strong year, marked by an impressive financial performance that drove the stock sharply higher mid-year. Investors will be keeping a close watch on the healthcare behemoth’s third-quarter earnings to check how it deals with macroeconomic challenges. The positive sentiment also reflects the company’s limited exposure […] The post Innovation pipeline, portfolio in focus ahead of Johnson & Johnson’s Q3 earnings first appeared on...

Johnson & Johnson (NYSE: JNJ) reported its second quarter 2025 earnings results today. Reported sales increased 5.8% year-over-year to $23.7 billion. Operational sales growth was 4.6%. Net earnings grew over […] The post Key highlights from Johnson & Johnson’s (JNJ) Q2 2025 earnings results first appeared on AlphaStreet.

Johnson & Johnson’s (NYSE: JNJ) business strategy for fiscal 2025 is focused on reducing the impact of patent expirations on its revenue. Anticipating sales to benefit from growth initiatives, including […] The post Johnson & Johnson to report Q2 earnings on July 16. Here’s what to expect first appeared on AlphaStreet.

Johnson & Johnson (NYSE: JNJ) reported its first quarter 2025 earnings results today. Reported sales increased 2.4% year-over-year to $21.8 billion. Operational sales growth was 4.2%. Net earnings rose to […] The post JNJ Earnings: Key quarterly highlights from Johnson & Johnson’s Q1 2025 financial results first appeared on AlphaStreet.

For Johnson & Johnson (NYSE: JNJ), investments in the pipeline and exiting lower priority businesses remain central to its strategy in the new fiscal year. The healthcare behemoth is in […] The post Deals and R&D in focus as Johnson & Johnson (JNJ) gears up for Q1 earnings first appeared on AlphaStreet.

Johnson & Johnson planuje wydać w ciągu czterech lat ponad 55 mld USD na budowę czterech zakładów w USA. Zwiększenie nakładów firmy w rodzimym kraju jest związane z cłami wprowadzanymi przez Donalda Trumpa - informuje Reuters.

Johnson & Johnson (NYSE: JNJ) reported its fourth quarter 2024 earnings results today. Reported sales increased 5.3% year-over-year to $22.5 billion. Operational sales growth was 6.7%. Net earnings decreased 17% […] The post JNJ Earnings: All you need to know about Johnson & Johnson’s Q4 2024 earnings results first appeared on AlphaStreet.

Johnson & Johnson (NYSE: JNJ) is set to publish its December-quarter report on January 22, amid expectations for mixed results. The company, which has faced both challenges and tailwinds in […] The post Johnson & Johnson (JNJ) likely to report mixed results for Q4 2024 first appeared on AlphaStreet.